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Plants  are  a  large  source  of  new  bioactive  molecules  with  therapeutic  potentials.  However,  only  a small
amount  of  worldwide  plants  have  been  phytochemically  investigated.  The  aqueous  and  ethanolic  extracts
of  Pistacia  lentiscus  L., Anacardiaceae,  leaves  were  evaluated  for hypocholesterolemic  activity  in vivo.  In
this  study,  hypercholesterolemia  was  induced  in  animals  by  feeding  them  high  cholesterol  (1%)  food.  The
extracts of P. lentiscus  were  orally  administered  at a dose  of  200  mg/kg  body  weight  along  with  a  high
cholesterol  diet for thirty  successive  days.  Lipid  parameters  such  as  total  cholesterol,  triacylglyceride,
low  density  lipoprotein,  very  low  density  lipoprotein  and  high  density  lipoprotein  were  measured  in
the  plasma.  Total  phenol  and  ﬂavonoid  contents  were  also  evaluated.  Flavonoid  content  was  found  to
be more  present  in the  ethanolic  extract  (8.218  ±  0.009  mg  of  QE/g)  compared  to  the  aqueous  extract
(3.107  ±  0.014  mg  of  QE/g).  The  administration  of  P. lentiscus  extracts  produced  a signiﬁcant  decrease  in
total  cholesterol,  triacylglyceride  and low density  lipoprotein-cholesterol  (154.6  ±  18.10,  71.2 ±  4.38 and
99.36  ± 18.77  mg/dl  respectively)  in the ethanolic  extract,  while  the  aqueous  extract  showed  a  signiﬁcant
decrease  in  total  cholesterol  and  triacylglyceride  (203.6  ± 9.18  and  97.6  ±  3.57  mg/dl  respectively).  The
results  of  the investigation  demonstrated  that  P. lentiscus  leaf  extract  has  hypocholesterolemic  properties
and might  be  used  for  the  prevention  of hypercholesterolemia  associated  disorders.
©  2015  Sociedade  Brasileira  de  Farmacognosia.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Increases in cholesterol levels (hypercholesterolemia) have
ecome a signiﬁcant health concern in recent years. Hypercho-
esterolemia is known to be a risk factor for the development
f cardiovascular diseases including atherosclerosis, myocardial
nfarction and cerebral paralysis (Avcı et al., 2006). This dysfunc-
ion also enhances free radical generation in various ways (Prasad
nd Kalra, 1993), as well as the formation of oxygen free radicals,
uch as superoxide anion radical or peroxynitrite, which play a sig-
iﬁcant role in the pathogenesis of many other diseases including,
ancer and inﬂammatory disorders (Das et al., 2000).
Curing hypercholesterolemia without any side effects remains
 challenge for modern medicine. Plant-derived products are fre-
uently considered to be less toxic, with few or no side effects, than
heir synthetic equivalents. Plants play a major role in the introduc-
ion of new therapeutic agents, and have received much attention
s sources of biologically active substances. Mastic (Pistacia
entiscus) is one such example.
∗ Corresponding author.
E-mail: m.cheurfa@univ-chlef.dz (M.  Cheurfa).
http://dx.doi.org/10.1016/j.bjp.2015.02.011
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier EditoraP. lentiscus is very common in the Mediterranean region. In Alge-
ria, mastic is found in both the Tell region and in forested areas. The
aerial portion has traditionally been used as both a stimulant and
a diuretic in the treatment of hypertension, coughs, sore throats
and stomach aches. P. lentiscus leaves contain bioactive molecules
such as phenolic compounds (proanthocyanidin tannins and gallic),
ﬂavonoid glycosides and anthocyanins.
The aim of this study is hence to study the hypocholesterolemic
activity in vivo of aqueous and ethanolic extracts of Algerian P.
lentiscus leaves.
Materials and methods
Plant material
Pistacia lentiscus L., Anacardiaceae, leaves were collected locally
from the Chlef region of Algeria in 2012. Voucher specimens were
collected under the registration number FSDB 12.189, at the herbar-
ium of Department of Biology, Faculty of Sciences, University of
Hassiba Ben Bouali-Chlef. They were identiﬁed by Ms.  Medjahed K,
a botanist at the Institute of Agronomy, University of Hassiba Ben
Bouali-Chlef. After drying in a shadow at room temperature, the
plant materials were fragmented.
 Ltda. All rights reserved.
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reparation of aqueous extract
The aqueous extract was prepared by decoction. Fragmented
eaves (100 g) were immerged in one liter of water at 100 ◦C for
5 min. The aqueous extract was ﬁltered through Whatman paper
◦ 1. The ﬁltrate was concentrated in a rotary vacuum evaporator
t 55 ◦C. The extraction yield was 11.88%.
reparation of ethanolic extract
The ethanolic extract was prepared by homogenizing 100 g of
ragmented leaves in 900 ml  of ethanol solution (50%) for three
ays, with frequent agitation. The ethanolic extract was ﬁltered
hrough Whatman paper N◦1. The solvent was removed from the
ample using a rotary vacuum evaporator at 48 ◦C (Peixoto et al.,
011). The extraction yield was 15.88%. All of the above dry extracts
ere stored at 4 ◦C in sterile glass jars and, sealed for use in further
tudies.
hytochemicals screening of the leaves extracts
etermination of total ﬂavonoid content
The total ﬂavonoid content in the extracts was determined spec-
rophotometrically using an aluminum chloride method involving
he formation of a ﬂavonoid–aluminum complex at 420 nm (Zhou
t al., 2005). The concentration of the total ﬂavonoid content was
alculated by comparison with the absorbance of different con-
entrations of quercetin (QE), and the result was expressed as
illigrams of QE equivalents per gram of plant powder. Samples
ere prepared in triplicate for each analysis, and the mean value
f absorbance was obtained.
ssay of hypocholesterolemic activity in vivo
nimals
Twenty-ﬁve male Swiss albino mice weighing between 25
nd 30 g were used in the present study. They were housed
n polypropylene cages with controlled levels of temperature
24 ± 2 ◦C) and light (a 12 h light, 12 h dark photoperiod), and fed
ith standard laboratory pellets. Food and water were given ad
ibitum.
The protocol employed was approved by the laboratory of tox-
cology and pharmacology (Antibiotical group – Medea, Algeria),
ollowing the recommendations of the European Pharmacopoeia
.0 under reference number 215/2013.
xperimental design
Hypercholesterolemia was induced in the mice via administer-
ng of food containing high cholesterol (1%) for thirty days. All
ice had free access to food and water for the duration of the
xperiment. The test group received 200 mg/kg body weight plant
xtracts at 10 ml/kg every morning, administered orally. The mice
ere divided into ﬁve groups of ﬁve animals each as follows:
Group 1: Received normal diet (control group).
Group 2: Fed with a high cholesterol diet and received 0.5 ml  of
sterile water, administered orally.
Group 3: Fed with a high cholesterol diet and received aqueous
extract of P. lentiscus, 200 mg/kg body weight for 30 days, admin-
istered orally.
Group 4: Fed with a high cholesterol diet and received ethanolic
extract of P. lentiscus, 200 mg/kg body weight for 30 days, admin-
istered orally.Farmacognosia 25 (2015) 142–144 143
Group 5: Fed with a high cholesterol diet and received reference
drug Atorvastatin, 10 mg/kg body weight (Khera and Bhatia, 2012)
for thirty days, administered orally.
At the end of the experiment, blood samples were collected from
the mice in all groups in vials without anti-coagulant. Biochemical
parameters measured in the study were TC (total cholesterol), TG
(triacylglyceride), LDL (low density lipoprotein), HDL (high density
lipoprotein) and VLDL (very low density lipoprotein), using assay
kits (Beckman Coulter, Ref: 467825, 445850, 969706, and 650207
– USA.).
Statistical analysis
The experimental results were expressed as mean SEM
(standard error of the man). Data were assessed by ANOVA. Tukey’s
test was then applied using XL Stat Pro 7.5 software. A p value of
<0.05 was considered to be statistically signiﬁcant.
Results
Flavonoid content
Flavonoid levels in the aqueous and ethanolic extracts of P.
lentiscus leaves were 3.107 ± 0.014 and 8.218 ± 0.009 mg  of QE/g
respectively. Ebrahimzadeh et al. (2008) tested the gum of P. lentis-
cus. They found the ﬂavonoid levels to be 30.52 ± 1.10 mg  of QE/g.
A ﬂavonoid content of 38.7 ± 0.02 mg  of QE/g was found by Cherbal
et al. (2012) for the methanol extract of P. lentiscus leaves.
Hypocholesterolemic activity in vivo
Table 1 shows the values of serum lipid proﬁle in the normal,
hypercholesterolemic, control and extract treated groups.
Cholesterol and triacylglyceride are important building blocks
in the structure of biological membranes. They are also used
in the biosynthesis of steroid hormones. However, high choles-
terol concentration in the blood increases the risk of developing
atherosclerosis and related cardiovascular diseases.
In the present study, mice fed with a high cholesterol
diet had higher (p < 0.05) levels of total cholesterol in the
serum (253 ± 31.60 mg/dl) than mice fed with a normal diet
(116 ± 0.89 mg/dl).
The treatment of group 3 with aqueous extract of P.
lentiscus at 200 mg/kg body weight, signiﬁcantly decreased TC
(203.6 ± 9.18 mg/dl) and TG (97. 6 ± 3. 57 mg/dl) compared to the
hypercholesterolemic control (group 2). However, there was no
signiﬁcant decrease in LDL-cholesterol.
In the cholesterol-fed mice (group 4), the treatment with
200 mg/kg body weight of P. lentiscus ethanolic extract also signif-
icantly decreased TC (154.6 ± 18.10 mg/dl), TG (71.2 ± 4.38 mg/dl)
and LDL-cholesterol (99.36 ± 18.77 mg/dl).
TC, TG and LDL-cholesterol also showed a signiﬁcant decrease
as compared to the high cholesterol-fed mice receiving 10 mg/kg
body weight doses of atorvastatin (group 5).
P. lentiscus leaf extracts showed a non-signiﬁcant increase of
HDL-cholesterol level in comparison to the hypercholesterolemic
control (group 2).
DiscussionFrom the results obtained, it is apparent that phenolic and
ﬂavonoid contents differ according to the plant and solvent used
during the extraction. Many factors can affect the content of phe-
nolic compounds. Recent studies have shown that extrinsic factors
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Table  1
Effect of aqueous and ethanolic extract of P. lentiscus on serum lipid proﬁle of mice fed with high cholesterol diet after 30 days.
Groups Dose (mg/kg) TC (mg/dl) TG (mg/dl) HDL-c (mg/dl) LDL-c (mg/dl) VLDL-c (mg/dl)
Control group 116 ± 0.89 146.4 ± 10.89 48.2 ± 6.40 38.52 ± 8.13 29.28 ± 2.17
Hypercholesterolaemic group 253 ± 31.60# 200 ± 12.32# 31.6 ± 1.74# 160 ± 31.60# 40 ± 2.46#
Aq P. lentiscus 200 203.6 ± 9.18* 97.6 ± 3.57*** 38.2 ± 1.48 145.88 ± 9.76 19.52 ± 0.71**
Et P. lentiscus 200 154.6 ± 18.10*** 71.2 ± 4.38*** 41 ± 1.87 99.36 ± 18.77* 14.24 ± 0.87**
Atorvastatin 10 130.6 ± 8.14*** 121.8 ± 42.65*** 62.8 ± 3.49*** 43.44 ± 9.35*** 24.36 ± 8.53
Aq: aqueous extract.
Et: ethanolic extract.
* p < 0.05 signiﬁcant from hypercholesterolaemic control.
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*** p < 0.001 signiﬁcant from hypercholesterolaemic control.
# p < 0.05 signiﬁcant from control animals.
such as geographic and climatic factors), genetic factors, degrees of
aturation of the plant, and storage time all have a strong inﬂuence
n the content of phenolic compounds (Falleh et al., 2008).
High levels of cholesterol in the diet have been shown to ele-
ate total cholesterol, and may  increase the risk of cardiovascular
omplications.
Regarding the cholesterol-lowering effect of P. lentiscus leaf
xtracts in mice fed with a high-cholesterol diet, the P. lentiscus
xtracts showed hypocholesterolemic properties. This may  be due
o either the individual or the synergistic action of the phenolic
omponents. A possible mechanism here may  be the hydroly-
is control of certain lipoproteins and their selective uptake and
etabolism by different tissues.
Flavonoids may  enhance the lecithin acyl transferase (LCAT) by
ncreasing their activity, which regulates blood lipids (Yoo et al.,
008). LCAT plays a key role in the incorporation of free cholesterol
nto HDL (this may  increase HDL) and its transfer back to VLDL and
DL, which are later returned in liver cells (Dobiásová and Frohlich,
999).
Flavonoids might represent another beneﬁcial group of nat-
rally occurring hypolipidemic compounds (Cook and Samman,
996), and they appear to have intensive biological properties
hat promote human health and help reduce the risk of disease.
lavonoids act as antioxidants, protect LDL cholesterol from oxida-
ion, inhibit platelet aggregation, and act as anti-inﬂammatory and
nti-tumor agents (Cook and Samman, 1996; Manach et al., 1996).
In addition to direct oxidant scavenging, ﬂavonoids may  inhibit
he enzymes involved in generating pro-oxidant molecules. For
xample, ﬂavonoids have been shown to inhibit the generation or
elease of free radicals derived from lipoxygenase (LOX). It has been
uggested that LOX is involved in the early events of atherosclero-
is by inducing plasma LDL oxidation in the subendothelial space
f the arterial wall (Huang et al., 1997).
In conclusion, the present study clearly demonstrates that P.
entiscus leaf extract is rich in phenolic compounds. Furthermore,
n terms of hypercholesterolemic activity, P. lentiscus extracts sig-
iﬁcantly decrease TC levels in plasma. Future studies are proposed
n order to conﬁrm these results.
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